Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$1.16 - $1.83 $70,029 - $110,477
-60,370 Reduced 81.34%
13,845 $20,000
Q3 2021

Nov 15, 2021

SELL
$3.11 - $4.75 $621,191 - $948,765
-199,740 Reduced 72.91%
74,215 $237,000
Q2 2021

Aug 11, 2021

BUY
$4.94 - $9.43 $488,738 - $932,957
98,935 Added 56.53%
273,955 $1.35 Million
Q1 2021

May 17, 2021

BUY
$1.43 - $15.48 $250,278 - $2.71 Million
175,020 New
175,020 $1.44 Million
Q2 2020

Aug 14, 2020

SELL
$0.8 - $2.1 $43,138 - $113,238
-53,923 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$1.0 - $6.05 $53,923 - $326,234
53,923 New
53,923 $54,000

About SECOND SIGHT MEDICAL PRODUCTS INC


  • Ticker EYES
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 13,136,400
  • Market Cap $54.4M
  • Description
  • Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulati...
More about EYES
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.